Paradigm Biopharmaceuticals Ltd
PAR
Company Profile
Business description
Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).
Contact
500 Collins Street
Level 15
Melbourne VIC 3000
AUST: +61 396295566
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
Stocks News & Analysis
stocks
Undervalued bank reports earnings
Shares jump but the operating environment remains difficult and we lower our fair value.
video
Impact of the supermarkets code of conduct
Morningstar Director of Equity Research Johannes Faul explains the impact of the political hot water that Coles and Woolworths face.
stocks
Four cheap wide moat ASX stocks
We follow Buffett’s adage to find great companies trading at attractive prices.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,892.10 | 31.10 | 0.40% |
| CAC 40 | 7,981.51 | 48.90 | 0.62% |
| DAX 40 | 17,770.02 | 3.79 | 0.02% |
| Dow JONES (US) | 37,753.31 | 45.66 | -0.12% |
| FTSE 100 | 7,847.99 | 27.63 | 0.35% |
| HKSE | 16,251.84 | 2.87 | 0.02% |
| NASDAQ | 15,683.37 | 181.88 | -1.15% |
| Nikkei 225 | 37,647.68 | 314.12 | -0.83% |
| NZX 50 Index | 11,799.54 | 75.81 | -0.64% |
| S&P 500 | 5,022.21 | 29.20 | -0.58% |
| S&P/ASX 200 | 7,635.30 | 29.70 | 0.39% |
| SSE Composite Index | 3,071.38 | 64.31 | 2.14% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -2.86% |
| Pantoro Ltd PNR | 0.08 | 0.00 | 1.83% |
| Renascor Resources Ltd RNU | 0.11 | 0.01 | 7.14% |
| Pilbara Minerals Ltd PLS | 3.88 | 0.04 | 1.04% |
| Telstra Group Ltd TLS | 3.68 | 0.01 | -0.14% |
| Evolution Mining Ltd EVN | 4.00 | 0.17 | -3.97% |
| Bellevue Gold Ltd BGL | 1.83 | 0.08 | -3.94% |
| Mesoblast Ltd MSB | 0.77 | 0.02 | 2.33% |
| Imugene Ltd IMU | 0.08 | 0.00 | 1.20% |
| The Star Entertainment Group Ltd SGR | 0.42 | 0.00 | 0.00% |